Related Experiment Videos
[Hemoperfusion of theophylline. An in vitro study]
K Derzsiová1, M Mydlík, V Petríková
1IV. interná klinika, Fakultná nemocnica s poliklinikou, Kosice.
Casopis Lekaru Ceskych
|January 4, 1991
Summary
Hemasorb 800 A-4 demonstrated superior in vitro theophylline removal compared to Hemasorb 800 A-2 during haemoperfusion. Researchers recommend Hemasorb 800 A-4 for treating acute theophylline intoxication in humans.
Area of Science:
- Pharmacology
- Biomaterials Science
- Toxicology
Context:
- Theophylline overdose is a significant clinical concern.
- Haemoperfusion is a potential extracorporeal method for drug removal.
- Evaluating novel adsorbent materials for enhanced drug clearance is crucial.
Purpose:
- To compare the in vitro efficacy of Hemasorb 800 C, A-2, and A-4 haemoperfusion capsules in removing theophylline.
- To determine the optimal Hemasorb material for theophylline clearance in a closed system.
Summary:
- Thirty in vitro haemoperfusions of theophylline were conducted using Hemasorb 800 C, A-2, and A-4 capsules with a constant perfusion solution.
- Hemasorb 800 A-4 showed sustained theophylline removal throughout the 5-hour perfusion, with detectable levels before and after the capsule.
- Hemasorb 800 A-2's adsorption capacity was exhausted by 180 minutes, indicating lower efficacy compared to A-4.
Impact:
- Hemasorb 800 A-4 is identified as the most effective material for in vitro theophylline haemoperfusion.
- The study recommends Hemasorb 800 A-4 for clinical application in managing acute theophylline intoxication.
- Findings contribute to the development of optimized haemoperfusion strategies for drug toxicity management.